The Niva Bupa Health Insurance IPO opened on November 7, 2024, and closes today, November 11. As of the latest data, it has received a 1.17x overall subscription. Retail investors led with a 1.54x subscription rate, while institutional buyers contributed 1.50x. With a price band of ₹70-74 per share and a lot size of 200 shares, Niva Bupa is seeing positive sentiment, reflected in a grey market premium (GMP) of ₹3, indicating a 4.03% premium above the upper price band.
Subscription Status and Allotment Details
| Investor Category | Subscription (Approx) |
|---|---|
| Qualified Institutional Buyers (QIBs) | 1.50x |
| Retail Individual Investors (RIIs) | 1.54x |
| Non-Institutional Investors (NIIs) | 0.43x |
The IPO proceeds will strengthen Niva Bupa’s capital and solvency levels. Allotments are expected by November 12, with shares crediting to demat accounts by November 13 and an anticipated debut on the NSE and BSE on November 14.
Should You Invest in Niva Bupa IPO?
Analysts suggest subscribing for the long term, noting Niva Bupa’s growth potential and robust demand among retail investors. However, factors like GMP fluctuations and market trends should be considered before investing.
For more IPO updates and insights, visit Surajgoswami.com.
